Efficacy and Safety of Meloxicam (Mobicox®) in Mexican Population With Rheumatic Diseases

NCT02184039 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12687

Last updated 2014-07-09

No results posted yet for this study

Summary

Study to evaluate the efficacy and safety of meloxicam (Mobicox®) in Mexican population with rheumatic diseases.

Conditions

Sponsors & Collaborators

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-05-31
Primary Completion
2004-07-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02184039 on ClinicalTrials.gov